YOLFTbeta
Sartorius Stedim Biotech SA

Sartorius Stedim Biotech SA

DIM · PA · Healthcare / Medical Instruments & Supplies

223.20EUR+0.40 (+0.18%)

Price History

Full chart

Market Stats

Previous Close222.80
Open223.40
Day Range222.20 – 224.60
52-Week Range150.00 – 223.09
Volume56.55K
Market Cap20.26B
P/E (TTM)68.94
Forward P/E35.84
EPS3.02
Dividend Yield0.33%
Beta1.15
50-Day Avg190.19
200-Day Avg181.70

About

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiology testing, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; screening instruments; biomolecule analysis tools; batch liquid chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; water purification systems; and weighing products. In addition, the company offers data analytics software; process automation platform and software; and transfection reagents and plasmid DNA solutions. The company has a collaboration with Bio Usawa Biotechnology, Ltd. focusing on developing and manufacturing monoclonal antibodies in Sub-Saharan Africa to tackle oncology, diabetes-induced eye diseases, infectious diseases, and autoimmune conditions. It serves manufacturers of medications, vaccines, food, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEODr. Rene Faber
  • Employees10.48K
  • HeadquartersZone Industrielle Les Paluds, Aubagne, France, 13781, France
  • Websitehttps://www.sartorius.com

Leadership

  • Dr. Rene FaberCEO & Director · b. 1975
  • Ms. Petra MullerHead of Investor Relations

Financials

Income Statement

Currency: EUR2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue484.30M521.05M268.84M368.00M401.23M432.95M477.30M543.96M588.38M683.52M884.33M1.05B1.08B1.21B1.44B1.91B2.89B3.49B2.78B2.78B2.97B
Growth (%)-+7.59%-48.41%+36.88%+9.03%+7.91%+10.24%+13.97%+8.16%+16.17%+29.38%+18.92%+2.80%+12.13%+18.84%+32.59%+51.14%+20.98%-20.53%+0.16%+6.74%
Cost of Revenue257.81M275.38M149.43M192.19M210.90M217.29M238.88M269.45M295.25M341.87M432.55M524.79M526.21M582.59M692.22M907.35M1.33B1.66B1.54B1.57B1.62B
Gross Profit226.49M245.68M119.41M175.81M190.33M215.66M238.42M274.51M293.13M341.65M451.79M526.82M554.83M629.56M748.35M1.00B1.55B1.82B1.23B1.21B1.35B
Gross Margin46.77%47.15%44.42%47.77%47.44%49.81%49.95%50.46%49.82%49.98%51.09%50.10%51.32%51.94%51.95%52.50%53.79%52.03%44.44%43.41%45.33%
Operating Expense4.96M435.00K105.49M142.08M141.72M155.76M167.26M187.31M191.78M221.28M267.25M300.90M333.12M329.33M416.32M530.92M640.34M716.20M749.00M836.10M796.30M
Operating Income221.53M245.24M13.91M33.73M48.61M59.89M71.16M87.20M101.35M120.37M184.53M225.92M221.70M300.23M332.02M471.81M912.67M1.10B484.50M370.60M549.00M
Operating Margin45.74%47.07%5.17%9.17%12.12%13.83%14.91%16.03%17.22%17.61%20.87%21.48%20.51%24.77%23.05%24.70%31.61%31.53%17.46%13.33%18.50%
EBITDA53.82M65.31M29.27M50.00M71.65M83.31M91.10M113.36M129.05M152.85M225.91M270.91M279.59M360.07M410.74M569.20M811.96M1.33B755.70M670.50M867.10M
EBITDA Margin11.11%12.54%10.89%13.59%17.86%19.24%19.09%20.84%21.93%22.36%25.55%25.76%25.86%29.71%28.51%29.80%28.12%38.10%27.23%24.12%29.22%
Net Income22.03M29.02M4.74M13.10M29.09M38.51M43.19M56.76M66.28M72.47M118.00M153.68M161.09M208.05M234.57M335.93M414.40M876.10M309.70M175.10M265.60M
Net Income Margin4.55%5.57%1.76%3.56%7.25%8.90%9.05%10.43%11.26%10.60%13.34%14.61%14.90%17.16%16.28%17.59%14.35%25.08%11.16%6.30%8.95%
R&D32.70M35.53M18.92M24.55M24.49M27.82M28.58M30.97M36.00M38.56M41.53M47.54M53.21M60.62M79.22M84.45M110.49M132.40M129.50M144.10M132.60M
R&D as % of Total Revenue6.75%6.82%7.04%6.67%6.10%6.43%5.99%5.69%6.12%5.64%4.70%4.52%4.92%5.00%5.50%4.42%3.83%3.79%4.67%5.18%4.47%
Interest Expense152.00K235.00K6.37M13.13M7.30M4.34M7.47M5.41M4.05M6.12M4.20M13.24M8.30M14.61M19.95M37.73M23.68M41.00M121.10M158.90M152.70M
Interest Expense % of Total Revenue0.03%0.05%2.37%3.57%1.82%1.00%1.56%0.99%0.69%0.90%0.47%1.26%0.77%1.21%1.39%1.98%0.82%1.17%4.36%5.72%5.15%

Balance Sheet

Currency: EUR2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets362.53M377.34M640.72M652.34M667.86M656.34M720.66M793.87M871.23M906.76M1.07B1.20B1.40B1.57B1.82B3.07B3.95B5.07B7.74B8.26B8.02B
Total Liabilities214.18M208.41M277.96M280.70M274.66M291.27M325.04M359.14M389.39M368.25M418.92M432.29M524.45M526.59M642.79M1.59B2.22B2.55B5.07B4.23B3.89B
Total Equity148.35M168.93M362.76M369.77M393.20M365.07M393.97M432.00M478.34M532.48M641.44M758.00M872.03M1.04B1.16B1.46B1.66B2.45B2.64B3.99B4.09B
Cash9.86M8.04M7.46M13.22M54.85M29.66M46.83M27.81M35.60M18.54M31.83M34.76M32.55M23.98M27.64M59.76M223.63M107.10M116.60M678.90M426.10M
Total Debt70.58M62.43M161.29M163.28M142.49M132.42M146.94M141.50M165.56M105.98M118.26M102.32M159.67M149.63M135.34M586.78M625.52M1.14B3.68B2.87B2.60B
Net Debt60.72M54.39M153.83M150.06M87.64M102.76M100.12M113.69M129.95M87.44M86.43M67.56M127.12M125.66M107.70M527.02M401.89M1.03B3.57B2.19B2.17B

Cash Flow

Currency: EUR2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow43.85M51.72M26.02M47.23M91.86M72.76M60.59M48.93M90.11M111.31M142.79M156.66M174.69M227.29M310.13M416.88M695.97M612.30M746.40M815.10M538.60M
Investing Cash Flow-11.74M-31.31M-13.61M26.65M-14.69M-15.30M-41.85M-32.94M-73.41M-46.81M-106.33M-102.73M-194.93M-176.54M-184.37M-621.12M-465.23M-957.50M-2.72B-340.00M-397.70M
Financing Cash Flow-31.66M-22.42M-6.52M14.39M-35.39M-82.50M-4.86M-34.30M-8.01M-84.21M-27.23M-50.10M16.62M-59.59M-122.16M234.07M-71.71M220.70M1.99B84.90M-389.20M
Capital Expenditure13.79M31.21M13.68M20.23M16.05M16.68M38.55M38.78M29.28M47.07M52.98M79.71M126.83M176.54M135.97M159.19M323.99M430.60M473.60M339.80M393.20M
Free Cash Flow30.06M20.51M12.34M27.00M75.81M56.07M22.04M10.14M60.83M64.25M89.80M76.95M47.86M50.75M174.16M257.69M695.97M181.70M156.10M475.30M145.40M
Dividends Paid6.99M8.69M-5.07M5.08M10.18M13.78M15.32M16.88M18.41M19.97M30.73M38.71M42.40M52.54M31.34M62.68M116.10M132.70M67.10M67.10M
FCF to OCF68.55%39.66%47.41%57.16%82.53%77.07%36.38%20.73%67.51%57.72%62.89%49.12%27.40%22.33%56.16%61.81%100.00%29.67%20.91%58.31%27.00%
Dividend Paid to FCF23.25%42.39%-18.78%6.70%18.16%62.52%151.07%27.74%28.66%22.23%39.94%80.88%83.55%30.17%12.16%9.01%63.90%85.01%14.12%46.15%

Earnings

Report DateMar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Oct 21, 2013Jan 28, 2014Mar 31, 2014Jul 22, 2014Oct 21, 2014Jan 27, 2015Apr 14, 2015Jul 21, 2015Oct 20, 2015Feb 1, 2016Apr 20, 2016Jul 25, 2016Oct 24, 2016Jan 30, 2017Apr 24, 2017Jul 21, 2017Oct 25, 2017Jan 31, 2018Apr 24, 2018Jul 24, 2018Oct 23, 2018Feb 19, 2019Apr 18, 2019Jul 19, 2019Oct 21, 2019Jan 28, 2020Apr 20, 2020Jul 20, 2020Oct 19, 2020Feb 17, 2021Apr 21, 2021Jul 20, 2021Oct 19, 2021Feb 17, 2022Apr 21, 2022Jul 21, 2022Oct 18, 2022Jan 26, 2023Apr 19, 2023Jul 21, 2023Oct 18, 2023Jan 26, 2024Apr 18, 2024Jul 18, 2024Oct 17, 2024Jan 27, 2025Apr 15, 2025Jul 22, 2025Oct 15, 2025Feb 2, 2026Apr 22, 2026Jul 22, 2026Oct 22, 2026
EPS Estimate----------------------0.000.00-0.00-0.000.000.000.000.000.000.000.540.410.510.510.490.520.530.550.590.590.600.670.690.750.760.900.951.131.451.731.881.822.012.903.092.282.001.892.790.870.941.020.841.020.941.051.011.301.211.281.18
EPS Actual0.030.050.020.020.050.060.090.070.070.100.110.120.120.100.130.120.150.140.190.150.150.220.160.180.170.200.210.200.200.350.450.270.390.470.510.500.480.490.460.530.510.610.620.640.680.740.730.700.870.951.201.141.641.852.031.942.212.192.182.061.431.190.850.720.860.850.761.031.161.180.941.121.171.25-
Surprise-----------------------------------5.56%21.95%-5.88%-3.92%-6.12%1.92%-3.77%10.91%5.08%8.47%13.33%10.45%5.80%-6.67%14.47%5.56%26.32%0.89%13.10%6.94%7.98%6.59%9.95%-24.48%-29.45%-9.65%-28.50%-37.04%-69.53%-17.24%-8.51%-16.67%-9.52%0.98%23.40%12.38%-6.93%-13.85%-3.31%-2.34%-
Timing--------------------------Pre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-market-Pre-marketPre-market--Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap20.26B
Enterprise Value22.20B
Trailing P/E68.94
Forward P/E35.84
PEG Ratio1.48
Price / Sales6.74
Price / Book4.72
EPS3.02
Book Value43.74
Revenue (TTM)3.01B
Gross Profit (TTM)1.35B
EBITDA816.40M
Profit Margin9.74%
Operating Margin20.11%
Return on Equity7.09%
Return on Assets4.40%
Shares Outstanding97.29M
Shares Float27.62M
Beta1.15
Dividend Yield0.33%
Dividend Rate0.69
Payout Ratio22.92%

Dividends

20261×
0.69Mar 31, 2026
20251×
0.69Apr 2, 2025
20241×
0.69Apr 2, 2024
20231×
1.44Mar 30, 2023
20221×
1.26Mar 31, 2022
20211×
0.68Mar 29, 2021
20201×
0.34Jun 29, 2020
20191×
0.57Mar 29, 2019
20181×
0.46Apr 9, 2018
20171×
0.42Apr 7, 2017
20161×
0.33Apr 13, 2016
20151×
0.22Apr 10, 2015
20141×
0.20Apr 10, 2014
20131×
0.18Apr 16, 2013
20121×
0.17Apr 17, 2012
20111×
0.15Apr 26, 2011
20101×
0.10Apr 27, 2010
20091×
0.05Apr 27, 2009
20081×
0.05Apr 25, 2008
20071×
0.03May 30, 2007
20061×
0.03Jul 7, 2006
20051×
0.02Jul 12, 2005
20041×
0.02Jul 9, 2004
20031×
0.02Jul 10, 2003

Stock Splits

  • May 6, 2016501503:83584
  • Jun 16, 20055:1
  • Jul 13, 200498163:89239
  • Jul 15, 200398163:89239
  • Jul 12, 200298163:89239
  • Jul 11, 200198163:89239
  • May 5, 199711:10
  • Jan 29, 1996301:292